[HTML][HTML] Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma
haematologica, 2012•ncbi.nlm.nih.gov
Background Plasma thymus and activation-regulated chemokine is a potential biomarker for
classical Hodgkin's lymphoma. To define its value as a marker to monitor treatment
response, we correlated serial plasma thymus and activation-regulated chemokine levels
with clinical response in newly diagnosed and relapsed classical Hodgkin's lymphoma
patients.
classical Hodgkin's lymphoma. To define its value as a marker to monitor treatment
response, we correlated serial plasma thymus and activation-regulated chemokine levels
with clinical response in newly diagnosed and relapsed classical Hodgkin's lymphoma
patients.
Abstract
Background
Plasma thymus and activation-regulated chemokine is a potential biomarker for classical Hodgkin’s lymphoma. To define its value as a marker to monitor treatment response, we correlated serial plasma thymus and activation-regulated chemokine levels with clinical response in newly diagnosed and relapsed classical Hodgkin’s lymphoma patients.
ncbi.nlm.nih.gov